B. Kupfer et al., Protection against parenteral HIV-1 infection by homozygous deletion in the C-C chemokine receptor 5 gene, AIDS, 13(9), 1999, pp. 1025-1028
Objectives: To investigate the role of the CC chemokine receptor 5 (CCR5) f
or parenteral transmission of HIV-1.
Design: The prevalence of the Delta 32 deletion within the CCR5 gene was de
termined in a cohort of 207 patients, who had received documented amounts o
f non-antibody-tested and non-inactivated clotting factor concentrate.
Methods: Chromosomal DNA of haemophiliacs was isolated from whole blood. A
portion of the CCR5 gene spanning the Delta 32 deletion was amplified by PC
R. The resulting DNA fragments were analysed by agarose gel electrophoresis
.
Results: The rate of HIV-1 infection was correlated strongly with increasin
g amounts of inoculated clotting factor concentrate. None of the HIV-positi
ve patients (n = 129) had the Delta 32/Delta 32 genotype, whereas 12 out of
78 HIV-negative haemophiliacs had the homozygous Delta 32 deletion.
Conclusions: The Delta 32/Delta 32 genotype was highly protective against H
IV-1 infection, even in patients who had received millions of non-inactivat
ed clotting factor units. As it is likely that in the early 1980s plasma po
ols were contaminated not only with monocyte-tropic HIV-1 strains, CCR5 app
ears to be the major mediator of HIV-1 infection. Furthermore, we conclude
that there must be other protective mechanisms in multiply exposed non-infe
cted haemophiliacs who have wild-type CCR5. (C) 1999 Lippincott Williams &
Wilkins.